JP6421124B2 - 医薬有効成分又は食品有効成分としての使用のための多孔質シリカ材料 - Google Patents

医薬有効成分又は食品有効成分としての使用のための多孔質シリカ材料 Download PDF

Info

Publication number
JP6421124B2
JP6421124B2 JP2015540176A JP2015540176A JP6421124B2 JP 6421124 B2 JP6421124 B2 JP 6421124B2 JP 2015540176 A JP2015540176 A JP 2015540176A JP 2015540176 A JP2015540176 A JP 2015540176A JP 6421124 B2 JP6421124 B2 JP 6421124B2
Authority
JP
Japan
Prior art keywords
silica
food
range
pores
silica material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015540176A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015536939A5 (https=
JP2015536939A (ja
Inventor
ロバート・サイカス
トーレ・ベングソン
ナタリア・クプフェルシュミット
アルフォンソ・イー・ガルシア−ベネット
Original Assignee
シグリッド・セラピューティクス・アーベー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by シグリッド・セラピューティクス・アーベー filed Critical シグリッド・セラピューティクス・アーベー
Publication of JP2015536939A publication Critical patent/JP2015536939A/ja
Publication of JP2015536939A5 publication Critical patent/JP2015536939A5/ja
Application granted granted Critical
Publication of JP6421124B2 publication Critical patent/JP6421124B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/015—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00—Silicon; Compounds thereof
    • C01B33/113—Silicon oxides; Hydrates thereof
    • C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/12—Surface area
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/14—Pore volume
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/16—Pore diameter
    • C01P2006/17—Pore diameter distribution
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Silicon Compounds (AREA)
JP2015540176A 2012-11-06 2013-11-06 医薬有効成分又は食品有効成分としての使用のための多孔質シリカ材料 Active JP6421124B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261723019P 2012-11-06 2012-11-06
US61/723,019 2012-11-06
PCT/EP2013/073200 WO2014072363A1 (en) 2012-11-06 2013-11-06 A porous silica material for use as a pharmaceutical or dietary active ingredient

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018194145A Division JP6752858B2 (ja) 2012-11-06 2018-10-15 医薬有効成分又は食品有効成分としての使用のための多孔質シリカ材料

Publications (3)

Publication Number Publication Date
JP2015536939A JP2015536939A (ja) 2015-12-24
JP2015536939A5 JP2015536939A5 (https=) 2016-12-22
JP6421124B2 true JP6421124B2 (ja) 2018-11-07

Family

ID=49639855

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015540176A Active JP6421124B2 (ja) 2012-11-06 2013-11-06 医薬有効成分又は食品有効成分としての使用のための多孔質シリカ材料
JP2018194145A Active JP6752858B2 (ja) 2012-11-06 2018-10-15 医薬有効成分又は食品有効成分としての使用のための多孔質シリカ材料

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018194145A Active JP6752858B2 (ja) 2012-11-06 2018-10-15 医薬有効成分又は食品有効成分としての使用のための多孔質シリカ材料

Country Status (20)

Country Link
US (2) US10695294B2 (https=)
EP (2) EP3892285A3 (https=)
JP (2) JP6421124B2 (https=)
CN (2) CN113069467A (https=)
AU (1) AU2013343565B2 (https=)
BR (1) BR112015010118A2 (https=)
CA (3) CA3024640A1 (https=)
CY (1) CY1124471T1 (https=)
DK (1) DK2916852T3 (https=)
ES (1) ES2878017T3 (https=)
HR (1) HRP20211036T1 (https=)
HU (1) HUE055017T2 (https=)
IL (1) IL238538B (https=)
LT (1) LT2916852T (https=)
PH (1) PH12015501010B1 (https=)
PL (1) PL2916852T3 (https=)
PT (1) PT2916852T (https=)
SI (1) SI2916852T1 (https=)
WO (1) WO2014072363A1 (https=)
ZA (1) ZA201502979B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3024640A1 (en) 2012-11-06 2014-05-15 Sigrid Therapeutics Ab A porous silica material for use as a pharmaceutical or dietary active ingredient
EP2934495B1 (en) * 2012-12-21 2017-07-19 National Health Research Institutes Mesoporous silica nanoparticles for oil absorption
US20200129444A1 (en) * 2017-07-13 2020-04-30 Carnegie Mellon University Method of Increasing Epithelial Permeability Using Nanoparticles
US20210085589A1 (en) * 2017-12-13 2021-03-25 L.I.Co.Rice S.R.L. Complex between lactoferrin and silica, process for the production thereof, and composition thereof for oral hygiene
GB201803363D0 (en) * 2018-03-01 2018-04-18 Sigrid Therapeutics Ab New materials and uses thereof
KR20210153080A (ko) * 2019-04-15 2021-12-16 나노로지카 에이비 퇴행성 신경질환, 뉴런 및 교세포의 치료, 예방 및/또는 퇴행 연기에 사용하기 위한 빈 다공성 입자.
CN110314151B (zh) * 2019-08-02 2020-06-02 深圳国佳产业基金管理有限公司 医用介孔二氧化硅材料及其应用
WO2021062538A1 (en) * 2019-09-30 2021-04-08 Zeroignition Technologies Inc. Thermally insulating and fire retardant material and method for making same
JP7578945B2 (ja) * 2020-10-27 2024-11-07 信越化学工業株式会社 イミダゾールシラン処理シリカからなる胆汁酸吸着剤
CN114195885B (zh) * 2022-01-12 2024-04-26 杭州隆基生物技术有限公司 一种单克隆抗体组合物提纯方法
CN118871077A (zh) 2022-02-04 2024-10-29 西格丽德治疗公司 包含多孔二氧化硅颗粒的口腔护理组合物
JP2025119063A (ja) 2022-04-28 2025-08-14 日本たばこ産業株式会社 無機多孔質材料を含む口腔用組成物
GB202212240D0 (en) 2022-08-23 2022-10-05 Sigrid Therapeutics Ab New formulations and medical uses thereof
GB202212239D0 (en) 2022-08-23 2022-10-05 Sigrid Therapeutics Ab New dietary supplements
CN116747321B (zh) * 2023-06-14 2025-09-05 厦门君德医药科技有限公司 一种接枝改性的介孔二氧化硅及其制备方法和应用
GB202312179D0 (en) 2023-08-09 2023-09-20 Sigrid Therapeutics Ab New compositions and uses
GB202312176D0 (en) 2023-08-09 2023-09-20 Sigrid Therapeutics Ab New uses and methods

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4185088A (en) 1977-02-17 1980-01-22 Merck & Co., Inc. Non-adhesive ionene quaternary polymer compositions useful as bile acid sequestrants
US4180566A (en) 1978-05-15 1979-12-25 W. R. Grace & Co. Silica gel method of reducing blood lipid concentration
US4824672A (en) * 1986-06-06 1989-04-25 Hauser-Kuhrts, Inc. Method and composition for reducing serum cholesterol
US5401466A (en) * 1993-06-01 1995-03-28 Miles Inc. Device for the direct measurement of low density lipoprotein cholesterol
EP0778027A3 (de) 1995-12-04 1998-04-01 Helmut Univ.-Prof. Dr. Wachter Verwendung von Kieselerde zur Herstellung von Arzneimitteln
EP0911078A1 (en) * 1997-10-20 1999-04-28 Hitachi Metals, Ltd. Photocatalyst-supporting body and photocatalytic apparatus
WO2000000195A1 (en) * 1998-06-30 2000-01-06 Takeda Chemical Industries, Ltd. Pharmaceutical composition for the treatment of diabetes
HK1042051A1 (zh) * 1999-08-16 2002-08-02 Henceforth Hibernia Inc. 包含有催化生物拟态固形物的治疗及预防用药物，以及其制备和使用方法
NZ523684A (en) 2000-07-28 2005-04-29 F New pharmaceutical composition
US7074440B2 (en) * 2002-05-01 2006-07-11 Rulin Xiu Compositions and methods for body weight loss
JP2004345895A (ja) 2003-05-21 2004-12-09 Ajinomoto Co Inc メソポーラスシリカ及びその製造方法
JP2005289853A (ja) 2004-03-31 2005-10-20 Ajinomoto Co Inc 経口リン酸吸着剤
GB0515353D0 (en) 2005-07-27 2005-08-31 Psimedica Ltd Food
KR100857411B1 (ko) 2006-07-21 2008-09-08 한올제약주식회사 리파아제 저해제의 경구 투여용 방출조절 약학 제제 및이의 제조 방법
CN101939258B (zh) 2008-02-11 2014-05-14 纳诺洛吉卡股份公司 中孔材料的制造方法、这样生产的材料以及中孔材料的用途
TW200936130A (en) * 2008-02-26 2009-09-01 Lundbeck & Co As H Uses of indane compounds
US20110212055A1 (en) * 2008-03-25 2011-09-01 Commissiong John W Neurodegenerative disorders
JP2010065023A (ja) 2008-08-14 2010-03-25 Lion Corp 脂溶性ビタミンおよび／または脂溶性色素含有粉体
US8778401B2 (en) * 2008-10-28 2014-07-15 Agency For Science, Technology And Research Mesoporous material excipients for poorly aqueous soluble ingredients
DE102009026686A1 (de) * 2009-06-03 2010-12-23 Airbus France Anordnung zum Blitzschutz einer elektronischen Einheit
US20130058987A1 (en) 2010-03-17 2013-03-07 Nanologica Ab Enhanced folic acid fluorescent material, multifluorescent porous compositions of matter and potential applications thereof
WO2012004291A1 (en) * 2010-07-06 2012-01-12 Nanologica Ab Improved method for stem cell differentiation in vivo by delivery of morphogenes with mesoporous silica and corresponding pharmaceutical active ingredients.
GB201212866D0 (en) 2012-07-20 2012-09-05 Formac Pharmaceuticals Nv Dry granulates of mesoporous silica powders
CA3024640A1 (en) 2012-11-06 2014-05-15 Sigrid Therapeutics Ab A porous silica material for use as a pharmaceutical or dietary active ingredient
ES2821528T3 (es) 2012-11-14 2021-04-26 Grace W R & Co Composiciones que contienen un material biológicamente activo y un óxido inorgánico no ordenado
EP2934495B1 (en) 2012-12-21 2017-07-19 National Health Research Institutes Mesoporous silica nanoparticles for oil absorption

Also Published As

Publication number Publication date
WO2014072363A1 (en) 2014-05-15
EP2916852B1 (en) 2021-04-14
PL2916852T3 (pl) 2021-11-02
CA3024640A1 (en) 2014-05-15
PH12015501010A1 (en) 2015-07-27
DK2916852T3 (en) 2021-05-10
US20150258028A1 (en) 2015-09-17
AU2013343565A1 (en) 2015-05-21
CA2890171A1 (en) 2014-05-15
CN113069467A (zh) 2021-07-06
JP2019023222A (ja) 2019-02-14
JP6752858B2 (ja) 2020-09-09
BR112015010118A2 (pt) 2017-07-11
PT2916852T (pt) 2021-06-15
CY1124471T1 (el) 2022-07-22
ZA201502979B (en) 2024-09-25
LT2916852T (lt) 2021-06-25
HUE055017T2 (hu) 2021-10-28
IL238538B (en) 2019-06-30
US12121612B2 (en) 2024-10-22
ES2878017T3 (es) 2021-11-18
CA3024460A1 (fr) 2018-11-15
IL238538A0 (en) 2015-06-30
HRP20211036T1 (hr) 2021-10-01
CN105188720A (zh) 2015-12-23
US10695294B2 (en) 2020-06-30
CA2890171C (en) 2019-01-22
US20200390703A1 (en) 2020-12-17
SI2916852T1 (sl) 2021-08-31
EP2916852A1 (en) 2015-09-16
EP3892285A3 (en) 2021-11-17
AU2013343565B2 (en) 2018-07-26
EP3892285A2 (en) 2021-10-13
PH12015501010B1 (en) 2023-10-20
JP2015536939A (ja) 2015-12-24

Similar Documents

Publication Publication Date Title
JP6752858B2 (ja) 医薬有効成分又は食品有効成分としての使用のための多孔質シリカ材料
JP6196676B2 (ja) 官能化された炭酸カルシウムを含む速崩性固形投与製剤およびその製造方法
JP5240822B2 (ja) 多孔質セルロース凝集体及びその成型体組成物
JPWO2005073286A1 (ja) 多孔質セルロース凝集体及びその成型体組成物
EA021313B1 (ru) Таблетки для комбинированной терапии
TW201641120A (zh) 可分散的劑型
TW200803752A (en) Food-and-drink composition improved in hygroscopicity
CN102008477B (zh) 一种瑞舒伐他汀钙片药物组合物的制备方法
Saha et al. Rutin-loaded polymeric nanorods alleviate nephrolithiasis by inhibiting inflammation and oxidative stress in vivo and in vitro
CN100477999C (zh) 胶体果胶铋分散片
KR20190016216A (ko) 퀘세틴을 함유하는 나노에멀젼 조성물의 제조방법 및 이를 통해 제조된 퀘세틴을 함유하는 나노에멀젼 조성물
Kumar et al. Modified release bi-layered tablet of melatonin using β-cyclodextrin
TWI644688B (zh) 含有崩解性粒子組成物之口腔內崩解錠劑之製造方法
WO2019166656A1 (en) Highly structured porous silica materials and biological uses thereof
Sharma et al. Fast dissolving tablets of promethazine theoclate by using natural superdisintegrants
JP7267083B2 (ja) 還元型コエンザイムｑ１０を含む粉末組成物及び酸化防止剤
JP2005255618A (ja) 水難溶性活性成分および多孔質セルロース粒子含有固形製剤組成物。
Murata et al. Functions of chitosan-ferulic acid salt for prevention of hypertension
JP2005255619A (ja) 昇華性活性成分および多孔質セルロース粒子含有固形製剤組成物
JP4889978B2 (ja) 経口摂取用組成物
CN103099794B (zh) 维生素c包合物分散片
CN120771180A (zh) 一种用于缓解肥胖和/或促进肠道健康的组合物及用途
KR20250127825A (ko) 피부질환 개선효과를 가지는 테트라하이드로커큐민을 포함하는 탄산칼슘 마이크로입자의 제조방법
JP2021187858A (ja) 医薬製剤
JP2007022981A (ja) 血中アンモニア低減剤および血中アンモニア低減性飲食品

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161101

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20161101

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20170828

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20171002

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180104

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180305

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180604

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180914

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20181015

R150 Certificate of patent or registration of utility model

Ref document number: 6421124

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250